cilengitide has been researched along with cannabidiol in 1 studies
Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (cannabidiol) | Trials (cannabidiol) | Recent Studies (post-2010) (cannabidiol) |
---|---|---|---|---|---|
194 | 29 | 133 | 3,279 | 321 | 2,646 |
Protein | Taxonomy | cilengitide (IC50) | cannabidiol (IC50) |
---|---|---|---|
Cholinesterase | Equus caballus (horse) | 0.67 | |
Heat sensitive channel TRPV3 | Rattus norvegicus (Norway rat) | 0.75 | |
Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | 0.45 | |
Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 3.7 | |
Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 2.8 | |
Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | 5.9 | |
Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JG; Babij, P; Fotsch, C | 1 |
1 review(s) available for cilengitide and cannabidiol
Article | Year |
---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |